OPCI NY 2021
Details
Organised by
Date
- America/New_York
Ajay Kirtane
Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and...
Read MoreAjay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at New York Presbyterian Hospital. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency in Internal Medicine at the University of California – San Francisco. Dr. Kirtane is a practicing Cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYP/Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology.
Show LessAkiko Maehara
Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of...
Read MoreDr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of Intravascualr Imaging and MRI Core Laboratories at Cardiovascular Research Foundation In New York. She is an expert of intravascular imging (Intraascular ultrasound, Optical coherence tomography, Infrared spectroscopy) to detect vulnerable plauqe and optimize PCI.
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessAndrew Berke
Andrew Berke, MD, has been an interventional cardiologist at St. Francis Hospital for 30 years....
Read MoreAndrew Berke, MD, has been an interventional cardiologist at St. Francis Hospital for 30 years. He received his medical degree at Brown University. His postgraduate medical, cardiology, and interventional cardiology training were all at New York Presbyterian-Columbia, where he was also a full-time faculty member before entering private practice. He has been at the forefront of advances in interventional cardiology. His research interests and publications have spanned the gamut from TIMI to TAVI. Dr. Berke is looking forward to participating in future studies of intravascular imaging, integration of non-invasive modalities into the catheterization laboratory, and furthering catheter-based treatments for structural heart disease. He is a Fellow of the American College of Physicians, a Fellow of the American College of Cardiology, and a Fellow of the Society of Coronary Angiography and Interventions.
Show LessAzeem Latib
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical....
Read MoreWorks at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Show LessBalbir Singh
A chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in...
Read MoreA chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in 1 video on Wondr Medical. Balbir Singh generally speaks on Coronary Optical Coherence Tomography (OCT) and Left Main Stem (LMS).
Show LessBruce Samuels
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center...
Read MoreDr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Show LessChong Park
Dr. Chong Park, MD is an interventional cardiology specialist in Fresh Meadows, NY. Dr. Park...
Read MoreDr. Chong Park, MD is an interventional cardiology specialist in Fresh Meadows, NY. Dr. Park completed a residency at North Shore University Hospital. He currently practices at ST FRANCIS HOSPITAL and is affiliated with NewYork-Presbyterian/Queens. He accepts multiple insurance plans.
Show LessDavid Cohen
David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the...
Read MoreDavid J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years. Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices. Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessDavid Rizik
An interventional cardiology at HonorHealth Heart Group Scottsdale, Arizona, USA. Features in 2...
Read MoreAn interventional cardiology at HonorHealth Heart Group Scottsdale, Arizona, USA. Features in 2 videos on Wondr Medical. David Rizik generally speaks on Atrial Fibrillation, Chronic Heart Failure, Mitral regurgitation, Intravascular Ultrasound (IVUS), and Co-registration.
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show LessDuane Pinto
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree...
Read MoreDr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.
Show LessElazer Edelman
Elazer Edelman works at MIT, Boston, MA, USA.
Read MoreElazer Edelman works at MIT, Boston, MA, USA.
Show LessEvan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read MoreDr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show LessFarouc Jaffar
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and...
Read MoreDr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty.
Show LessGary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessGeorge Dangas
Works at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical....
Read MoreWorks at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical. George Dangas generally speaks on Cardiovascular Pharmacotherapy, Acute Coronary Syndromes (ACS), Primary Percutaneous Coronary Intervention (PPCI), Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Coronary Physiology.
Show LessGeorge Petrossian
George Petrossian, MD, is Director of Interventional Cardiovascular Procedures at St. Francis...
Read MoreGeorge Petrossian, MD, is Director of Interventional Cardiovascular Procedures at St. Francis Hospital, as well as Co-director of St. Francis Hospital’s Heart Valve Center. He is a board certified cardiologist and interventional cardiologist who has been a Principal Investigator for a number of nationwide studies that have transformed the treatment of heart disease. His pioneering research helped win FDA approval of CoreValve, a minimally invasive device that offers new hope for patients with aortic stenosis too frail to undergo open heart surgery. Dr. Petrossian has participated in multiple pivotal trials. His interests include left atrial appendage closure, and peripheral vascular disease.
Show LessGregg Stone
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic...
Read MoreGregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Show LessHabib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read MoreDr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show LessHector Garcia-Garcia
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart &...
Read MoreHector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.
Show LessHiram Bezerra
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director,...
Read MoreHiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Show LessJasvindar Singh
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization...
Read MoreDr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Show LessJennifer Tremmel
An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features...
Read MoreAn interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features in 2 videos on Wondr Medical. Jennifer Tremmel generally speaks on Coronary Interventions, Structural Cardiac Interventions, Microvascular Disease (MVD), and Stable Coronary Artery Disease (CAD).
Show LessJonathan Hill
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton...
Read MoreConsultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.
Show LessJuan Granada
Works at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr...
Read MoreWorks at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr Medical. Juan Granada generally speaks on Mitral, Repair/Replacement, Trans Mitral Valve Implantation (TMVR), Mitral regurgitation, and Bioresorbable Vascular Scaffold (BVS).
Show LessKate Kearney
An assistant professor of medicine at University of Washington Medical Center, Seattle, WA, USA....
Read MoreAn assistant professor of medicine at University of Washington Medical Center, Seattle, WA, USA. Features in 2 videos on Wondr Medical. Kathleen Kearney generally speaks on Chronic Heart Failure, Intravascular Ultrasound (IVUS), Left Main Stem (LMS), Atherectomy, and Coronary Interventions.
Show LessKevin Croce
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total...
Read MoreDr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.
Show LessKhady Fall
A physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr...
Read MoreA physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr Medical. Khady Fall generally speaks on Intravascular Ultrasound (IVUS) and Coronary Optical Coherence Tomography (OCT).
Show LessKi Park
Ki Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In...
Read MoreKi Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In addition to her professorship role, she is the director of women’s cardiovascular health at UF Health. Dr. Park received a bachelor’s degree in microbiology at the University of Florida. She also completed her internal medicine residency, general cardiology fellowship and interventional cardiology fellowship at the University of Florida College of Medicine. During her fellowship training, she also completed a Cardiovascular Cell Therapy Research Network Fellowship and earned a master of science in translational science through the APPCI program. In 2010, she received the UF Department of Medicine’s Excellence in Research Award as well as the American Heart Association’s Women in Cardiology Trainee Award for Excellence. Dr. Park partners with other UF Health cardiologists to create a dedicated team for targeted cardiovascular women’s care in Gainesville and throughout Florida. She has a number of research studies focused on women-specific cardiology care to help offer the latest technologies and research to her patients.
Show LessManesh Patel
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical...
Read MoreManesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.
Show LessMartin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read MoreMartin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show LessMichael Lee
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the...
Read MoreDr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.
Show LessMorton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read MoreDr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show LessNadia Sutton
An assistant professor of medicine at University of Michigan, Michigan, US. Features in 2 videos...
Read MoreAn assistant professor of medicine at University of Michigan, Michigan, US. Features in 2 videos on Wondr Medical. Nadia Sutton generally speaks on Shockwave Lithotripsy (Coronary).
Show LessNewell Robinson
Newell Robinson, MD, is Chairman of Cardiothoracic and Vascular Surgery at St. Francis Hospital,...
Read MoreNewell Robinson, MD, is Chairman of Cardiothoracic and Vascular Surgery at St. Francis Hospital, as well as Co-director of the Heart Valve Center at St. Francis Hospital. He is a board certified cardiothoracic surgeon who has been recognized nationally for his expertise in minimally-invasive cardiac surgery. As Co-Principal Investigator of the CoreValve clinical study, his published findings, helped gain FDA approval of the device. Dr. Robinson has also been pivotal in bringing state-of-the-art technology to St. Francis Hospital, including a hybrid OR that allows interventional cardiologists and cardiothoracic surgeons to work side by side for the benefit of patients. Dr. Robinson is consistently cited on New York magazine’ Best Doctors list, in addition to being rated among the top physicians in the country by Castle Connolly.
Show LessPaul Lee
Paul J. Lee, M.D., earned his medical degree at SUNY Buffalo in 1994. He completed his residency...
Read MorePaul J. Lee, M.D., earned his medical degree at SUNY Buffalo in 1994. He completed his residency at Montefiore Medical Center continuing at North Shore-Long Island Jewish, then completed his Interventional Cardiology Fellowship in 2002. He joined South Bay Cardiovascular in 2002, performing cardiac interventions at Good Samaritan and Southside Hospitals. In 2009, South Bay Cardiovascular affiliated with St. Francis Hospital, becoming one of the largest and most respected cardiovascular practices in the region. Dr. Lee specializes in treatment of complex coronary artery disease and peripheral vascular disease and TAVR procedures.
Show LessPaul Teirstein
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for...
Read MorePaul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Show LessRobert Busch
Dr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine...
Read MoreDr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine Group. Dr. Robert Busch received his B.A. from Brandeis University,and his Medical Degree from the University of Pennsylvania. He served his Internship, Residency,and was Chief Medical Resident at North Shore University Hospital,prior to his endocrinology fellowship at Albany Medical College.
Show LessRon Waksman
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital...
Read MoreRon Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Show LessRony Mathew
A senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India....
Read MoreA senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India. Features in 1 video on Wondr Medical. Rony Mathew generally speaks on Coronary Optical Coherence Tomography (OCT) and Bifurcation.
Show LessRoxana Mehran
A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr...
Read MoreA consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.
Show LessS Ajit Mullasari
A director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission,...
Read MoreA director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission, Chennai, India. Features in 2 videos on Wondr Medical. S Ajit Mullasari generally speaks on Fractional Flow Reserve (FFR), Instantaneous wave-Free Ratio (iFR), Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), and Rotational Atherectomy (PVD).
Show LessSripal Bangalore
Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York...
Read MoreDr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.
Show LessStéphane Rinfret
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic...
Read MoreDr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He was appointed chief of interventional cardiology at the McGill University Health Centre (MUHC) and associate professor of medicine at McGill University in 2016 where he built a very active chronic total occlusion (CTO) and Complex Higher-risk but Indicated Procedures (CHIP) program. He has now moved to the US to work with at Emory Healthcare and Emory University, as associate-director of complex PCI and full professor (acting) of Medicine, to pursue his academic career and busy clinical practice, mostly at Emory Saint Joseph's Hospital, the oldest hospital of Atlanta serving a very large population. Dr Rinfret has held several peer-reviewed grants, published over 150 peer-reviewed articles, several abstracts, and has been invited over 300 times to give lectures in the last 10 years. His epidemiological research focuses on health services and outcomes. He is also a high-volume and world-renown coronary operator, performing over 400 percutaneous coronary interventions (PCIs) per year, mostly from the transradial approach and most with complex anatomies. Dr Rinfret was one of the Canadian pioneers in CTO PCI and has contributed to expand access to the technique in Canada and all around the world through sharing his expertise. He is the lead editor of a textbook on CTO PCI published by Springer in 2015, currently being reviewed for a second edition. He has performed over 1200 CTO PCIs since January 2010, one of the largest volumes in the world, including a large number of retrograde procedures, and pursues a very active teaching program of transradial and CTO PCI techniques in Canada and Europe.
Show LessSunil Rao
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of...
Read MoreDr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessRobert Busch
Dr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine...
Read MoreDr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine Group. Dr. Robert Busch received his B.A. from Brandeis University,and his Medical Degree from the University of Pennsylvania. He served his Internship, Residency,and was Chief Medical Resident at North Shore University Hospital,prior to his endocrinology fellowship at Albany Medical College.
Show LessSGLT2 Inhibitors: A drug for Heart Failure, Diabetes or Renal disease? One Drug that does it all
Rita Jermyn
Dr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital....
Read MoreDr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital. She also holds an appointment as an assistant professor at the Albert Einstein College of Medicine where she completed her advanced heart failure and transplant fellowship. Her research interests include ambulatory pulmonary artery pressure monitoring, cardiometabolic syndrome, and mechanical circulatory support. She is board certified in cardiology and heart failure.
Show LessBalancing ischemic and bleeding risk: Contemporary use of anti-platelet and anti-thrombotic therapy following PCI
Darshan Doshi
Dr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who...
Read MoreDr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who specializes in complex coronary interventions. He also helps directs the chronic total occlusions program, and leads imaging and physiology efforts in the cath lab. Dr. Doshi received his BA from Columbia University’s Columbia College and his MD from Columbia University’s College of Physicians and Surgeons. He completed his internal medicine residency, and his cardiovascular medicine and interventional cardiology fellowships at the Columbia University Medical Center. Dr. Doshi also underwent additional dedicated training at Columbia in complex and high-risk interventional procedures. He was then recruited to join the faculty in the Division of Cardiology at the Massachusetts General Hospital. Dr. Doshi also holds a MS in patient-oriented research from Columbia University’s Mailman School of Public Health with a research interest focused on clinical trials evaluating novel cardiovascular devices and therapeutics in interventional cardiology. He has authored several original manuscripts in translational and clinical cardiovascular medicine, and has published in the New England Journal of Medicine, Lancet, Journal of the American College of Cardiology, and Circulation, among many others.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessJennifer Tremmel
An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features...
Read MoreAn interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features in 2 videos on Wondr Medical. Jennifer Tremmel generally speaks on Coronary Interventions, Structural Cardiac Interventions, Microvascular Disease (MVD), and Stable Coronary Artery Disease (CAD).
Show LessOlga Toleva
Dr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at...
Read MoreDr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at the University of British Columbia, Vancouver, Canada. She subsequently practiced as a Family physician and after a year in practice entered the Internal Medicine residency program at UBC, Vancouver. Dr. Toleva completed her training in Adult Cardiology and Interventional cardiology at the University of Alberta, Edmonton, Canada. During her cardiology fellowship she also completed Masters in Public Health at The Harvard School of Public Health. Dr. Toleva worked as an Assistant Professor in the University of Manitoba and an Interventional Cardiologist at St. Boniface Hospital from 2014 until March 2021. She was involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology. She focused on outcomes research, frailty, and quality of life assessments in the older adults who are the predominant population requiring TAVR. Dr. Olga Toleva just moved to the US and is a new Interventional Cardiologist at Emory Healthcare, primarily located at Emory St. Joseph's Hospital. She is involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology microvascular dysfunction invasive testing in the cardiac catheterization laboratory. Dr. Toleva has a strong interest in Women's Heart Health with clinical work and research related to the diagnosis and therapy of Spontaneous Coronary Artery Dissection (SCAD), Myocardial infarction without obstructive coronary artery disease (MINOCA), and Micro Vascular Dysfunction (MVD) - chest pain syndromes without obstructive coronary disease. She will be part of the Emory Women's Heart Health Clinic focusing on the care of patients and performing research in the area. These conditions are predominantly seen in women and continue to be poorly understood and under-treated. Dr. Toleva has a high volume PCI and TAVR practice and is very active in the world of coronary and structural heart research and innovation.
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessMartin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read MoreMartin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less-
Which drugs when in CMD - Bruce Samuels
-
Call it what you want, it’s all just GDMT - Duane Pinto
- Q&A with Panel Discussion
Bruce Samuels
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center...
Read MoreDr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Show LessDuane Pinto
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree...
Read MoreDr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.
Show LessHector Garcia-Garcia
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart &...
Read MoreHector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.
Show LessKhady Fall
A physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr...
Read MoreA physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr Medical. Khady Fall generally speaks on Intravascular Ultrasound (IVUS) and Coronary Optical Coherence Tomography (OCT).
Show LessHabib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read MoreDr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show LessAkiko Maehara
Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of...
Read MoreDr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of Intravascualr Imaging and MRI Core Laboratories at Cardiovascular Research Foundation In New York. She is an expert of intravascular imging (Intraascular ultrasound, Optical coherence tomography, Infrared spectroscopy) to detect vulnerable plauqe and optimize PCI.
Show Less-
It’s all about the flow – Why physiology guided PCI should be the standard - Ajay Kirtane
-
It’s all about the plaque–Why imaging rules it all - Gregg Stone
-
Q&A with Panel Discussion
- Stump the Panel–Unusual Left Main Cases - Rapid Fire - Gary Mintz
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessGeorge Dangas
Works at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical....
Read MoreWorks at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical. George Dangas generally speaks on Cardiovascular Pharmacotherapy, Acute Coronary Syndromes (ACS), Primary Percutaneous Coronary Intervention (PPCI), Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Coronary Physiology.
Show LessGregg Stone
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic...
Read MoreGregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Show LessRony Mathew
A senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India....
Read MoreA senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India. Features in 1 video on Wondr Medical. Rony Mathew generally speaks on Coronary Optical Coherence Tomography (OCT) and Bifurcation.
Show LessS Ajit Mullasari
A director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission,...
Read MoreA director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission, Chennai, India. Features in 2 videos on Wondr Medical. S Ajit Mullasari generally speaks on Fractional Flow Reserve (FFR), Instantaneous wave-Free Ratio (iFR), Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), and Rotational Atherectomy (PVD).
Show LessBalbir Singh
A chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in...
Read MoreA chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in 1 video on Wondr Medical. Balbir Singh generally speaks on Coronary Optical Coherence Tomography (OCT) and Left Main Stem (LMS).
Show LessJasvindar Singh
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization...
Read MoreDr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Show LessSunil Rao
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of...
Read MoreDr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”
Show LessRon Waksman
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital...
Read MoreRon Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Show LessFarouc Jaffer
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and...
Read MoreDr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty. Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath. Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.
Show Less• Expansion matters more
• Q&A with Panel Discussion
Hiram Bezerra
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director,...
Read MoreHiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Show LessPaul Teirstein
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for...
Read MorePaul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Show LessKi Park
Ki Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In...
Read MoreKi Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In addition to her professorship role, she is the director of women’s cardiovascular health at UF Health. Dr. Park received a bachelor’s degree in microbiology at the University of Florida. She also completed her internal medicine residency, general cardiology fellowship and interventional cardiology fellowship at the University of Florida College of Medicine. During her fellowship training, she also completed a Cardiovascular Cell Therapy Research Network Fellowship and earned a master of science in translational science through the APPCI program. In 2010, she received the UF Department of Medicine’s Excellence in Research Award as well as the American Heart Association’s Women in Cardiology Trainee Award for Excellence. Dr. Park partners with other UF Health cardiologists to create a dedicated team for targeted cardiovascular women’s care in Gainesville and throughout Florida. She has a number of research studies focused on women-specific cardiology care to help offer the latest technologies and research to her patients.
Show LessPanelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessRobert Riley
Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and...
Read MoreDr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and high-risk coronary artery disease and cardiogenic shock. He focuses on the treatment of coronary chronic total occlusions, multivessel coronary artery disease (including patients turned down for CABG surgery), atherectomy, and those in need of mechanical circulatory support. He was born in Knoxville, TN and completed his undergraduate education at Furman University with a degree in Chemistry. He attended medical school at the University of Virginia and completed residency in Internal Medicine at the University of Washington. He then completed his Cardiology fellowship at Wake Forest University, during which he obtained a Masters degree in Clinical and Population Translational Science. He then returned to the University of Washington to complete his Interventional Cardiology fellowship, followed by the first ever advanced fellowship in Complex, High-Risk, and Indicated PCI and Hemodynamic Support before joining the group at Christ Hospital. He is very active in clinical research, co-edits a monthly newsletter on high-risk PCI, and enjoys speaking at national and international meetings.
Show LessPanelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessMorton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read MoreDr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show Less• Lessons from the ISCHEMIA trial – Cover the plaque for better outcomes
• Q&A with Panel Discussion
Dimitri Karmpaliotis
Director of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics,...
Read MoreDirector of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics, Morristown Medical Center Dimitrios Karmpaliotis, MD, PhD, FACC, FSCAI is Medical Director of the Cardiovascular Rescue and Recovery Program and the Advanced Coronary Therapeutics and Chronic Total Occlusions Program at Morristown Medical Center. Dr. Karmpaliotis was formerly at the Center for Interventional Vascular Therapy at Columbia University Medical Center, where he provided world-class care since 2014. He is a former associate professor of medicine at Columbia University Medical School and formerly served as director of the Chronic Total Occlusions, Complex and High-Risk Angioplasty Program at New York-Presbyterian/Columbia University Medical Center.
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessStéphane Rinfret
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic...
Read MoreDr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He was appointed chief of interventional cardiology at the McGill University Health Centre (MUHC) and associate professor of medicine at McGill University in 2016 where he built a very active chronic total occlusion (CTO) and Complex Higher-risk but Indicated Procedures (CHIP) program. He has now moved to the US to work with at Emory Healthcare and Emory University, as associate-director of complex PCI and full professor (acting) of Medicine, to pursue his academic career and busy clinical practice, mostly at Emory Saint Joseph's Hospital, the oldest hospital of Atlanta serving a very large population. Dr Rinfret has held several peer-reviewed grants, published over 150 peer-reviewed articles, several abstracts, and has been invited over 300 times to give lectures in the last 10 years. His epidemiological research focuses on health services and outcomes. He is also a high-volume and world-renown coronary operator, performing over 400 percutaneous coronary interventions (PCIs) per year, mostly from the transradial approach and most with complex anatomies. Dr Rinfret was one of the Canadian pioneers in CTO PCI and has contributed to expand access to the technique in Canada and all around the world through sharing his expertise. He is the lead editor of a textbook on CTO PCI published by Springer in 2015, currently being reviewed for a second edition. He has performed over 1200 CTO PCIs since January 2010, one of the largest volumes in the world, including a large number of retrograde procedures, and pursues a very active teaching program of transradial and CTO PCI techniques in Canada and Europe.
Show Less• Optimal Bifurcation PCI – A planned 2-stent strategy - don’t hesitate!
• Q&A with Panel Discussion/Wrap-up
Azeem Latib
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical....
Read MoreWorks at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Show LessMichael Lee
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the...
Read MoreDr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show LessElazer Edelman
Elazer Edelman works at MIT, Boston, MA, USA.
Read MoreElazer Edelman works at MIT, Boston, MA, USA.
Show LessOri Ben-Yehuda
Ori Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular...
Read MoreOri Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation. A graduate of Tel Aviv University, he completed his fellowship in cardiology at the University of California, San Diego. From 1997 to 2011 he was the Director of the Coronary Care Unit at UCSD where he was also Professor of Medicine. He also served as the Deputy Editor of the Journal of the American College of Cardiology and is presently the Deputy Editor of Structural Heart: the Journal of the Heart Team. Dr. Ben-Yehuda is involved in the design and execution of multiple clinical trials in interventional cardiology.
Show LessManesh Patel
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical...
Read MoreManesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.
Show Less• Vulnerable plaque detection is a pipe-dream
• Q&A with Panel Discussion
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessJuan Granada
Works at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr...
Read MoreWorks at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr Medical. Juan Granada generally speaks on Mitral, Repair/Replacement, Trans Mitral Valve Implantation (TMVR), Mitral regurgitation, and Bioresorbable Vascular Scaffold (BVS).
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessDavid Cohen
David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the...
Read MoreDavid J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years. Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices. Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.
Show LessEvan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read MoreDr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less